CareCloud (CCLD) Director Anne Busquet Receives RSUs and Converts Units

What Happened

• Anne Busquet, a director of CareCloud, received a grant of 25,000 restricted stock units (RSUs) on July 29, 2026 (reported as an "A" award, $0 paid).
• On July 31, 2026 the filing reports conversion/exercise entries for 6,250 RSUs into common stock (reported as "M" derivative conversion) at $0 per share — the filing and footnotes state these shares were issued upon vesting under the company’s equity plan and were acquired without payment. The total reported consideration for these transactions is $0.

Key Details

• Transaction dates and prices:
  • 2026-07-29: Grant of 25,000 RSUs (A) — $0 paid.
  • 2026-07-31: Conversion of 6,250 RSUs into common stock (M) — $0 paid.
• Shares owned after transaction: not specified in the Form 4 provided.
• Footnotes:
  • F1: The 25,000 RSU grant vests in four equal installments on Jan 29, 2027; Jul 29, 2027; Jan 29, 2028; and Jul 29, 2028.
  • F2: The 6,250-unit conversion reflects RSUs vesting into common stock on Jul 31, 2026 under the company’s Amended and Restated Equity Incentive Plan; no cash payment by the reporting person.
• Filing timeliness: the Form 4 shows filing date July 31, 2026 for transactions on July 29 and July 31; the filing does not indicate a late-report flag.

Context

• These transactions are equity compensation (RSU grant and conversion on vesting), not open-market purchases or sales. RSU grants are a common form of director compensation and do not necessarily signal a personal cash investment or change in sentiment.
• The derivative entries reflect conversion of vested RSUs into shares (no exercise price paid), not an option exercise requiring cash. The vesting schedule means the remaining RSUs will convert over the next two years if vesting conditions are met.